Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Evidence of a Local Mechanism for Desmopressin-Induced Tissue-Type Plasminogen Activator Release in Human Forearm

View through CrossRef
Systemic administration of desmopressin (DDAVP) induces increased plasma levels of tissue-type plasminogen activator (t-PA), coagulation factor VIII, and von Willebrand factor (vWF). However, the mechanisms behind these responses are not known. We tested the hypothesis that DDAVP acts as a local stimulator of acute endothelial release of t-PA and vWF independently of central pathways. Healthy, young, nonsmoking male volunteers were studied. In a first study (n = 7), DDAVP and placebo were administered as randomized single-blind stepwise intrabrachial artery infusions (0.7, 7.0, and 70 ng/min). In a another subset of subjects (n = 4), a constant-rate DDAVP infusion of 70 ng/min was administered for 20 minutes in the brachial artery of the nondominant arm with the dominant arm as control. To rule out that the observed t-PA release was flow-dependent, 4 additional subjects received stepwise intra-arterial infusions of both DDAVP (7.0, 21, and 70 ng/min) and sodium nitroprusside (SNP; 0.5, 2.5, and 10 μg/min). Brachial venoarterial plasma concentration gradients and forearm plasma flow were used to determine net release/uptake rates of t-PA and vWF. At baseline, the average net release rate of t-PA was 6.7 ng/min across the whole forearm vascular bed, whereas there was no detectable basal release of vWF. Stepwise infusion of DDAVP induced a massive regulated release of t-PA with a peak after 15 minutes on the highest dose-step (ANOVA; P < .0001). The average maximum net release rate was 178 ng/min, and the total amount of t-PA released was, on the average, 3,000 ng. The majority was released in its active form. Constant-rate DDAVP infusion again markedly increased t-PA release in the infusion arm but had no effect whatsoever in the control arm. In contrast, DDAVP did not stimulate a local release of vWF in either study. Central hemodynamics were unchanged during infusions despite a local vasodilatory response with DDAVP. Endothelium-independent flow stimulation by SNP did not elicit any local t-PA release. We conclude that DDAVP induces a massive acute flow-independent release of t-PA, without the simultaneous release of vWF, in the human forearm vascular bed. The lack of a t-PA response in the control arm, as well as the unaltered central hemodynamics with DDAVP, confirms that the observed regulated t-PA release is local and independent of central mechanisms.
Title: Evidence of a Local Mechanism for Desmopressin-Induced Tissue-Type Plasminogen Activator Release in Human Forearm
Description:
Systemic administration of desmopressin (DDAVP) induces increased plasma levels of tissue-type plasminogen activator (t-PA), coagulation factor VIII, and von Willebrand factor (vWF).
However, the mechanisms behind these responses are not known.
We tested the hypothesis that DDAVP acts as a local stimulator of acute endothelial release of t-PA and vWF independently of central pathways.
Healthy, young, nonsmoking male volunteers were studied.
In a first study (n = 7), DDAVP and placebo were administered as randomized single-blind stepwise intrabrachial artery infusions (0.
7, 7.
0, and 70 ng/min).
In a another subset of subjects (n = 4), a constant-rate DDAVP infusion of 70 ng/min was administered for 20 minutes in the brachial artery of the nondominant arm with the dominant arm as control.
To rule out that the observed t-PA release was flow-dependent, 4 additional subjects received stepwise intra-arterial infusions of both DDAVP (7.
0, 21, and 70 ng/min) and sodium nitroprusside (SNP; 0.
5, 2.
5, and 10 μg/min).
Brachial venoarterial plasma concentration gradients and forearm plasma flow were used to determine net release/uptake rates of t-PA and vWF.
At baseline, the average net release rate of t-PA was 6.
7 ng/min across the whole forearm vascular bed, whereas there was no detectable basal release of vWF.
Stepwise infusion of DDAVP induced a massive regulated release of t-PA with a peak after 15 minutes on the highest dose-step (ANOVA; P < .
0001).
The average maximum net release rate was 178 ng/min, and the total amount of t-PA released was, on the average, 3,000 ng.
The majority was released in its active form.
Constant-rate DDAVP infusion again markedly increased t-PA release in the infusion arm but had no effect whatsoever in the control arm.
In contrast, DDAVP did not stimulate a local release of vWF in either study.
Central hemodynamics were unchanged during infusions despite a local vasodilatory response with DDAVP.
Endothelium-independent flow stimulation by SNP did not elicit any local t-PA release.
We conclude that DDAVP induces a massive acute flow-independent release of t-PA, without the simultaneous release of vWF, in the human forearm vascular bed.
The lack of a t-PA response in the control arm, as well as the unaltered central hemodynamics with DDAVP, confirms that the observed regulated t-PA release is local and independent of central mechanisms.

Related Results

SUMMARY
SUMMARY
SUMMARYThe purpose of the present monograph is to give an account of the distribution of fibrinolytic components in the organism, with special reference to the tissue activator of ...
Effects of desmopressin on thrombogenesis in aspirin‐induced platelet dysfunction
Effects of desmopressin on thrombogenesis in aspirin‐induced platelet dysfunction
Summary. Aspirin causes a coagulation disorder. Desmopressin has haemostatic effects by increasing the plasma levels of coagulation factor VIII and von Willebrand factor. The preci...
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
The metabolism of plasminogen glycoforms I and II was measured in alloxan-induced diabetic and in age-matched control rabbits. Radiolabeled plasminogen I and II were degraded signi...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets activated in platelet-rich p...
Plasminogen interactions with platelets in plasma
Plasminogen interactions with platelets in plasma
Abstract In this report we used a fluorescent flow cytometry-based assay to examine plasminogen binding to platelets in plasma. Our data indicate that platelets acti...
Minimally Invasive Plate Osteosynthesis of Comminuted One Bone Fractures of Forearm Shaft
Minimally Invasive Plate Osteosynthesis of Comminuted One Bone Fractures of Forearm Shaft
Objective: Due to rotatability of the forearm, open reduction and internal fixation with plate is a gold standard treatment of forearm fracture. Our hypothesis was that if it does ...
Further Characterization Of SK-Potentiator Of Plasminogen
Further Characterization Of SK-Potentiator Of Plasminogen
Streptokinase (SK) forms a complex with human plasminogen (plg) or plasmin, and the resulting complex (SK-activator) functions to convert plg to plasmin. We have indicated that hum...

Back to Top